Logo image of EYE

NATIONAL VISION HOLDINGS INC (EYE) Stock Fundamental Analysis

USA - NASDAQ:EYE - US63845R1077 - Common Stock

22.99 USD
-0.27 (-1.16%)
Last: 9/12/2025, 8:00:02 PM
22.99 USD
0 (0%)
After Hours: 9/12/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, EYE scores 3 out of 10 in our fundamental rating. EYE was compared to 121 industry peers in the Specialty Retail industry. EYE has a medium profitability rating, but doesn't score so well on its financial health evaluation. EYE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year EYE was profitable.
EYE had a positive operating cash flow in the past year.
In multiple years EYE reported negative net income over the last 5 years.
In the past 5 years EYE always reported a positive cash flow from operatings.
EYE Yearly Net Income VS EBIT VS OCF VS FCFEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

The Return On Assets of EYE (-0.72%) is comparable to the rest of the industry.
EYE's Return On Equity of -1.66% is in line compared to the rest of the industry. EYE outperforms 52.07% of its industry peers.
EYE has a Return On Invested Capital (2.65%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EYE is significantly below the industry average of 12.11%.
The last Return On Invested Capital (2.65%) for EYE is above the 3 year average (1.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROIC 2.65%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
EYE Yearly ROA, ROE, ROICEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

With a Operating Margin value of 2.76%, EYE perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
EYE's Operating Margin has declined in the last couple of years.
EYE has a better Gross Margin (58.61%) than 87.60% of its industry peers.
In the last couple of years the Gross Margin of EYE has grown nicely.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 58.61%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
EYE Yearly Profit, Operating, Gross MarginsEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

EYE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
EYE has more shares outstanding than it did 1 year ago.
EYE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EYE has an improved debt to assets ratio.
EYE Yearly Shares OutstandingEYE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EYE Yearly Total Debt VS Total AssetsEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.08 indicates that EYE is not a great score, but indicates only limited risk for bankruptcy at the moment.
EYE has a Altman-Z score (2.08) which is comparable to the rest of the industry.
EYE has a debt to FCF ratio of 4.80. This is a neutral value as EYE would need 4.80 years to pay back of all of its debts.
EYE's Debt to FCF ratio of 4.80 is fine compared to the rest of the industry. EYE outperforms 65.29% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that EYE is not too dependend on debt financing.
EYE has a Debt to Equity ratio (0.30) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Altman-Z 2.08
ROIC/WACC0.29
WACC9.14%
EYE Yearly LT Debt VS Equity VS FCFEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

EYE has a Current Ratio of 0.52. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EYE (0.52) is worse than 91.74% of its industry peers.
EYE has a Quick Ratio of 0.52. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.31, EYE is not doing good in the industry: 73.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.31
EYE Yearly Current Assets VS Current LiabilitesEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.00% over the past year.
The Earnings Per Share has been decreasing by -7.68% on average over the past years.
EYE shows a decrease in Revenue. In the last year, the revenue decreased by -4.45%.
Measured over the past years, EYE shows a small growth in Revenue. The Revenue has been growing by 1.12% on average per year.
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%

3.2 Future

The Earnings Per Share is expected to grow by 21.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, EYE will show a small growth in Revenue. The Revenue will grow by 5.71% on average per year.
EPS Next Y26.91%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EYE Yearly Revenue VS EstimatesEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
EYE Yearly EPS VS EstimatesEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 38.32, EYE can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as EYE.
EYE's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 27.49, the valuation of EYE can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as EYE.
EYE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.73.
Industry RankSector Rank
PE 38.32
Fwd PE 27.49
EYE Price Earnings VS Forward Price EarningsEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EYE is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, EYE is valued a bit cheaper than the industry average as 62.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 32.09
EV/EBITDA 14.54
EYE Per share dataEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

EYE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as EYE's earnings are expected to grow with 21.75% in the coming years.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y23.3%
EPS Next 3Y21.75%

0

5. Dividend

5.1 Amount

No dividends for EYE!.
Industry RankSector Rank
Dividend Yield N/A

NATIONAL VISION HOLDINGS INC

NASDAQ:EYE (9/12/2025, 8:00:02 PM)

After market: 22.99 0 (0%)

22.99

-0.27 (-1.16%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners114.07%
Inst Owner Change-1.99%
Ins Owners2.09%
Ins Owner Change6.15%
Market Cap1.82B
Analysts81.33
Price Target29.43 (28.01%)
Short Float %10.21%
Short Ratio3.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.89%
Min EPS beat(2)9.52%
Max EPS beat(2)30.26%
EPS beat(4)4
Avg EPS beat(4)34.01%
Min EPS beat(4)9.52%
Max EPS beat(4)83.55%
EPS beat(8)8
Avg EPS beat(8)45.05%
EPS beat(12)11
Avg EPS beat(12)16.75%
EPS beat(16)15
Avg EPS beat(16)81.36%
Revenue beat(2)2
Avg Revenue beat(2)1.45%
Min Revenue beat(2)0.41%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.98%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)8
Avg Revenue beat(16)-0.24%
PT rev (1m)5.68%
PT rev (3m)53.46%
EPS NQ rev (1m)1.42%
EPS NQ rev (3m)12.23%
EPS NY rev (1m)7.3%
EPS NY rev (3m)8.02%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 38.32
Fwd PE 27.49
P/S 0.97
P/FCF 32.09
P/OCF 12.58
P/B 2.14
P/tB N/A
EV/EBITDA 14.54
EPS(TTM)0.6
EY2.61%
EPS(NY)0.84
Fwd EY3.64%
FCF(TTM)0.72
FCFY3.12%
OCF(TTM)1.83
OCFY7.95%
SpS23.81
BVpS10.74
TBVpS-1.21
PEG (NY)1.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.66%
ROCE 3.36%
ROIC 2.65%
ROICexc 2.74%
ROICexgc 7.41%
OM 2.76%
PM (TTM) N/A
GM 58.61%
FCFM 3.01%
ROA(3y)-0.87%
ROA(5y)0.91%
ROE(3y)-2.25%
ROE(5y)2.22%
ROIC(3y)1.97%
ROIC(5y)3.59%
ROICexc(3y)2.16%
ROICexc(5y)4.2%
ROICexgc(3y)5.73%
ROICexgc(5y)11.7%
ROCE(3y)2.5%
ROCE(5y)4.55%
ROICexcg growth 3Y-36.81%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-36.88%
ROICexc growth 5Y-10.66%
OM growth 3Y-36.53%
OM growth 5Y-14.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.94%
GM growth 5Y1.77%
F-Score6
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 4.8
Debt/EBITDA 1.82
Cap/Depr 99.27%
Cap/Sales 4.66%
Interest Coverage 2.69
Cash Conversion 102.87%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.31
Altman-Z 2.08
F-Score6
WACC9.14%
ROIC/WACC0.29
Cap/Depr(3y)109.9%
Cap/Depr(5y)102.38%
Cap/Sales(3y)5.81%
Cap/Sales(5y)5.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.94%
EPS 5Y-7.68%
EPS Q2Q%20%
EPS Next Y26.91%
EPS Next 2Y23.3%
EPS Next 3Y21.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.45%
Revenue growth 3Y-4.29%
Revenue growth 5Y1.12%
Sales Q2Q%7.68%
Revenue Next Year6.74%
Revenue Next 2Y5.07%
Revenue Next 3Y5.71%
Revenue Next 5YN/A
EBIT growth 1Y58.39%
EBIT growth 3Y-39.25%
EBIT growth 5Y-13.48%
EBIT Next Year196.32%
EBIT Next 3Y49.89%
EBIT Next 5YN/A
FCF growth 1Y80.13%
FCF growth 3Y-38.43%
FCF growth 5Y-9.78%
OCF growth 1Y0.91%
OCF growth 3Y-19.78%
OCF growth 5Y-4.14%